Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM30645 (US8853193, 32-28) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279238 ((Z)-3-({4-[N-Acetyl-(3-dimethylaminopropyl)-amino]...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136194 (US8853193, 23-3) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM98036 (US8486953, 19) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279080 ((Z)-3-[(4-{Methyl-[2-(4-methylpiperazin-1-yl)acety...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136277 (US8853193, 32.7) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279080 ((Z)-3-[(4-{Methyl-[2-(4-methylpiperazin-1-yl)acety...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | MMDB PDB Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279267 ((Z)-3-({4-[N-Acetyl-(2-dimethylaminoethyl)-amino]-...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM98040 (US8486953, 53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279237 ((Z)-3-{[4-(N-Acetyl-dimethylcarbamoylmethyl-amino)...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136283 (US8853193, 32-44) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136193 (US8853193, 23-2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279236 ((Z)-3-({4-[(2-Imidazol-1-yl-acetyl)methylamino]-ph...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136262 (US8853193, 53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279236 ((Z)-3-({4-[(2-Imidazol-1-yl-acetyl)methylamino]-ph...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279082 ((Z)-6-Nitro-3-[phenyl-(4-piperidin-1-ylmethyl-phen...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279238 ((Z)-3-({4-[N-Acetyl-(3-dimethylaminopropyl)-amino]...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM30642 (US8853193, 32-27) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136201 (US8853193, 23-10) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136202 (US8853193, 24) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM30641 (US8853193, 32-26) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136200 (US8853193, 23-9) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136258 (US8853193, 49) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279236 ((Z)-3-({4-[(2-Imidazol-1-yl-acetyl)methylamino]-ph...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279267 ((Z)-3-({4-[N-Acetyl-(2-dimethylaminoethyl)-amino]-...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279237 ((Z)-3-{[4-(N-Acetyl-dimethylcarbamoylmethyl-amino)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136175 (US8853193, 16-2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136199 (US8853193, 23-8) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136275 (US8853193, 32-5) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM30636 (US8853193, 32-21) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM31312 (US8853193, 32-37) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136195 (US8853193, 23-4) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279238 ((Z)-3-({4-[N-Acetyl-(3-dimethylaminopropyl)-amino]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279237 ((Z)-3-{[4-(N-Acetyl-dimethylcarbamoylmethyl-amino)...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136260 (US8853193, 51) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | KEGG PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136197 (US8853193, 23-6) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279268 ((Z)-3-({4-[(2-Dimethylaminoethyl)-methanesulfonyl-...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human)) | BDBM50279045 ((Z)-3-({4-[(2-Dimethylamino-acetyl)-methyl-amino]-...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR3 | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136263 (US8853193, 54) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279269 ((Z)-3-({4-[(3-Dimethylaminopropyl)-methyl-carbamoy...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136284 (US8853193, 32-45) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136219 (US8853193, 31-5) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136185 (US8853193, 21-3) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136257 (US8853193, 48) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha (Homo sapiens (Human)) | BDBM50279268 ((Z)-3-({4-[(2-Dimethylaminoethyl)-methanesulfonyl-...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human PDGFRalpha | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM50279267 ((Z)-3-({4-[N-Acetyl-(2-dimethylaminoethyl)-amino]-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharma GmbH&Co KG Curated by ChEMBL | Assay Description Inhibition of human VEGFR2 expressed in Sf9 cells | J Med Chem 52: 4466-80 (2009) Article DOI: 10.1021/jm900431g BindingDB Entry DOI: 10.7270/Q2RB75JS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136188 (US8853193, 21-6) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM32187 (US8853193, 32-42) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136281 (US8853193, 32-12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MAP kinase-interacting serine/threonine-protein kinase 2 (Homo sapiens (Human)) | BDBM136282 (US8853193, 32-43) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 30 |
Boehringer Ingelheim International GmbH US Patent | Assay Description Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The... | US Patent US8853193 (2014) BindingDB Entry DOI: 10.7270/Q2GX4983 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1196 total ) | Next | Last >> |